0001437749-14-003442.txt : 20140305
0001437749-14-003442.hdr.sgml : 20140305
20140305105658
ACCESSION NUMBER: 0001437749-14-003442
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140303
FILED AS OF DATE: 20140305
DATE AS OF CHANGE: 20140305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Altieri Richard M.
CENTRAL INDEX KEY: 0001592351
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 14667806
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC
STREET 2: 94C INNOVATION DRIVE
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2014-03-03
0001586049
Oxford Immunotec Global PLC
OXFD
0001592351
Altieri Richard M.
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
Chief Financial Officer
Ordinary Shares
2014-03-03
4
A
0
28720
0
A
28720
D
SHARE OPTION (RIGHT TO BUY)
22.99
2014-03-03
4
A
0
28720
0
A
2024-03-03
Ordinary Shares
28720
28720
D
Option granted under Issuer's 2013 Share Incentive Plan.
Will become exercisable as to 1,795 shares on April 1, 2014 and will become exercisable as to the remainder ratably on the first day of each month from May 1, 2014 through January 1, 2018.
/s/ Elizabeth M. Keiley, as Attorney-in-Fact
2014-03-05